Cencora Inc. (COR)vsHenry Schein Inc (HSIC)
COR
Cencora Inc.
$320.46
+1.42%
HEALTHCARE · Cap: $59.59B
HSIC
Henry Schein Inc
$88.08
-0.06%
HEALTHCARE · Cap: $9.77B
Smart Verdict
WallStSmart Research — data-driven comparison
Cencora Inc. generates 2356% more annual revenue ($328.68B vs $13.38B). HSIC leads profitability with a 3.0% profit margin vs 0.8%. COR appears more attractively valued with a PEG of 0.66. COR earns a higher WallStSmart Score of 64/100 (C+).
COR
Buy64
out of 100
Grade: C+
HSIC
Buy52
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-74.8%
Fair Value
$181.48
Current Price
$320.46
$138.98 premium
Margin of Safety
+46.2%
Fair Value
$151.74
Current Price
$88.08
$63.66 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 75 in profit
Earnings expanding 128.3% YoY
Safe zone — low bankruptcy risk
Large-cap with strong market position
Growing faster than its price suggests
Generating 1.2B in free cash flow
No standout strengths identified
Areas to Watch
Trading at 18.4x book value
3.8% revenue growth
0.8% margin — thin
Operating margin of 1.7%
Expensive relative to growth rate
Moderate valuation
4.5% earnings growth
3.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : COR
The strongest argument for COR centers on Return on Equity, EPS Growth, Altman Z-Score. PEG of 0.66 suggests the stock is reasonably priced for its growth.
Bull Case : HSIC
HSIC has a balanced fundamental profile.
Bear Case : COR
The primary concerns for COR are Price/Book, Revenue Growth, Profit Margin. Debt-to-equity of 3.65 is elevated, increasing financial risk. Thin 0.8% margins leave little buffer for downturns.
Bear Case : HSIC
The primary concerns for HSIC are PEG Ratio, P/E Ratio, EPS Growth. Thin 3.0% margins leave little buffer for downturns.
Key Dynamics to Monitor
HSIC carries more volatility with a beta of 0.81 — expect wider price swings.
HSIC is growing revenue faster at 6.3% — sustainability is the question.
COR generates stronger free cash flow (1.2B), providing more financial flexibility.
Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
COR scores higher overall (64/100 vs 52/100). HSIC offers better value entry with a 46.2% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cencora Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.
Henry Schein Inc
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
Visit Website →Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?